Calcidiol Draft Committee Advice for Review Discussion Paper
On this pageSkip the menu of subheadings on this page.
Committee Paper for Discussion - ACNFP/162/03
Advisory Committee for Novel Foods and Processes
Application for Authorisation as a Novel Food for Calcidiol - Draft committee advice for review.
Application number RP35
This Calcidiol dossier has been discussed at five meetings. The Secretariat were asked to prepare a Committee Advice Assessment summarising the assessment to date, this was developed and reviewed at the April 2023 meeting. The Committee requested the Secretariat to revise this draft further in light of the comments received. The revised draft is presented for further comment and input with a view to finalising the document.
1. On the 12th of January 2021, the FSA (Food Standards Agency) received the submission for “Calcidiol” from DSM Nutritional Products Ltd (Switzerland). Calcidiol is a new form of Vitamin D for use as a food supplement targeted at a generally healthy population including pregnant and lactating women, except children under 3 years. It is a vitamer of vitamin D3 (cholecalciferol) and is directly absorbed by the human body.
2. The Committee formally requested that the ACNFP Secretariat draft a Committee Advise document for this novel food. This has been developed and comments are sought on the draft found in Annex A.
Committee Action Required
- The Committee is asked to review and comment on the draft Committee Advice for this novel food.
Annex A – Draft Committee Advice Document